[Molecular drug research: an overview of mechanism-oriented serine protease inhibitors]

Real-world survival benefit of adding durvalumab to chemotherapy in cholangiocarcinoma: a retrospective cohort analysis from a German Comprehensive Cancer Centre.

ESMO real world data and digital oncology·2026

Detection of macrovesicular steatosis in hematoxylin and eosin-stained histological images of human livers: A feature-based method.

Journal of pathology informatics·2026

Glucocorticoid-prescribing trends in congenital adrenal hyperplasia, 2017 to 2023.

Endocrine connections·2026

Preoperative immunotherapy with atezolizumab and tiragolumab in patients with colorectal liver metastases-the PURPLE trial.

ESMO gastrointestinal oncology·2026

Fostering school reintegration after psychiatric inpatient treatment: description and study protocol of an evaluation study about a rehabilitation program for children and adolescents with chronic school refusal (SchuTIng-stAR).

Frontiers in child and adolescent psychiatry·2025

PERSPECTIVE: Treatment with hydrocortisone modified-release capsules in children and adolescents with congenital adrenal hyperplasia: an expert opinion.

Endocrine connections·2025

Strengthening Pharmaceutical Quality Control Laboratories: Inspection-Ready Implementation of the World Health Organization Good Practices for Pharmaceutical Quality Control Laboratories and Pathways to Prequalification.

Die Pharmazie·2026

The Potential Mechanism of Dihydroartemisinin in the Treatment of Thyroid Cancer Through Network Pharmacological Analysis.

Die Pharmazie·2026

GA Eases Atherosclerosis by Regulating Circadian Rhythm.

Die Pharmazie·2026

Lipid Metabolism, Statins and Bleeding Risk During Anticoagulant Therapy: Emerging Pharmacological Insights.

Die Pharmazie·2026

Hydroxysafflor Yellow A Alleviates Ischemic Stroke Through Modulation of GPX4-Associated Ferroptosis: Computational Simulation and Animal Validation.

Die Pharmazie·2026

Visual Differentiation of Bupleurum marginatum var. stenophyllum From Bupleurum chinense DC. Using a PCR-Coupled G-Quadruplex Colorimetric Assay.

Die Pharmazie·2026

CSK-DDI: Compensating Structural Incompleteness with Knowledge Graph World Knowledge for Drug-Drug Interaction Modeling.

Bioinformatics (Oxford, England)·2026

Evaluation of capsid inhibitor resistance profiles and HIV-1 subtype distribution via near-full-length genome NGS in ART-naive HIV-1 patients in Guangxi, China.

The Journal of antimicrobial chemotherapy·2026

Antihypertensive drug-induced liver injury is rare, but strongly associated with HLA-B∗35:01.

Acta pharmaceutica Sinica. B·2026

Erratum: Author correction to "Chemical screen identifies shikonin as a broad DNA damage response inhibitor that enhances chemotherapy through inhibiting ATM and ATR" [Acta Pharm Sin B 12 (2022) 1339-1350].

Acta pharmaceutica Sinica. B·2026

Discovery of a potent covalent inhibitor for the treatment of sepsis targeting DNAJC9: Identification of a druggable target for inflammation.

Acta pharmaceutica Sinica. B·2026

Identification and characterization of a non-nucleotide RdRp allosteric inhibitor with pan-coronavirus protection.

Acta pharmaceutica Sinica. B·2026

Related Experiment Videos

[Molecular drug research: an overview of mechanism-oriented serine protease inhibitors]

Related Concept Videos

Real-world survival benefit of adding durvalumab to chemotherapy in cholangiocarcinoma: a retrospective cohort analysis from a German Comprehensive Cancer Centre.

Detection of macrovesicular steatosis in hematoxylin and eosin-stained histological images of human livers: A feature-based method.

Glucocorticoid-prescribing trends in congenital adrenal hyperplasia, 2017 to 2023.

Preoperative immunotherapy with atezolizumab and tiragolumab in patients with colorectal liver metastases-the PURPLE trial.

Fostering school reintegration after psychiatric inpatient treatment: description and study protocol of an evaluation study about a rehabilitation program for children and adolescents with chronic school refusal (SchuTIng-stAR).

PERSPECTIVE: Treatment with hydrocortisone modified-release capsules in children and adolescents with congenital adrenal hyperplasia: an expert opinion.

Strengthening Pharmaceutical Quality Control Laboratories: Inspection-Ready Implementation of the World Health Organization Good Practices for Pharmaceutical Quality Control Laboratories and Pathways to Prequalification.

The Potential Mechanism of Dihydroartemisinin in the Treatment of Thyroid Cancer Through Network Pharmacological Analysis.

GA Eases Atherosclerosis by Regulating Circadian Rhythm.

Lipid Metabolism, Statins and Bleeding Risk During Anticoagulant Therapy: Emerging Pharmacological Insights.

Hydroxysafflor Yellow A Alleviates Ischemic Stroke Through Modulation of GPX4-Associated Ferroptosis: Computational Simulation and Animal Validation.

Visual Differentiation of Bupleurum marginatum var. stenophyllum From Bupleurum chinense DC. Using a PCR-Coupled G-Quadruplex Colorimetric Assay.

CSK-DDI: Compensating Structural Incompleteness with Knowledge Graph World Knowledge for Drug-Drug Interaction Modeling.

Evaluation of capsid inhibitor resistance profiles and HIV-1 subtype distribution via near-full-length genome NGS in ART-naive HIV-1 patients in Guangxi, China.

Antihypertensive drug-induced liver injury is rare, but strongly associated with HLA-B∗35:01.

Erratum: Author correction to "Chemical screen identifies shikonin as a broad DNA damage response inhibitor that enhances chemotherapy through inhibiting ATM and ATR" [Acta Pharm Sin B 12 (2022) 1339-1350].

Discovery of a potent covalent inhibitor for the treatment of sepsis targeting DNAJC9: Identification of a druggable target for inflammation.

Identification and characterization of a non-nucleotide RdRp allosteric inhibitor with pan-coronavirus protection.

Related Experiment Videos

[Molecular drug research: an overview of mechanism-oriented serine protease inhibitors]

Related Concept Videos

Related Articles